Day: January 5, 2024

Sodexo Q1 Fiscal 2024: strong organic revenue growth at +8.2%

Written by Customer Service on January 5, 2024. Posted in Public Companies.

Issy-les-Moulineaux, January 5, 2024Sodexo (NYSE Euronext Paris FR 0000121220-OTC: SDXAY) Sodexo Q1 Fiscal 2024: strong organic revenue growth at +8.2%High single digit Underlying growth in all zones Full year Fiscal 2024 guidance maintained Q1 FISCAL 2024 REVENUESREVENUES(in million euros) Q1 FY24 Q1 FY23 ORGANICGROWTH EXTERNALGROWTH CURRENCYEFFECT TOTALGROWTHNorth America 3,030 2,992 +8.7% +0.1% -7.6% +1.3%Europe 2,196 2,047 +9.2% -0.8% -1.2% +7.3%Rest of the World 1,061 1,057 +4.7% -0.2% -4.2% +0.3%SODEXO 6,287 6,097 +8.2% -0.3% -4.8% +3.1%Note 1: These numbers exclude any contribution from Pluxee which as a discontinued activity is consolidated only at the net profit level. Note 2: The impact from Q4 2023 of the accounting change related to revenue recognition in a large Energy & Resources contract...

WISeKey and Cybersecurity Tech Accord to Host an Influential Roundtable Discussion During Davos 2024 Event

Written by Customer Service on January 5, 2024. Posted in Public Companies.

The Roundtable “AI Unleashed – Ensuring Safety and Leveraging Decentralization” Will Take Place on January 17, 2024 in Davos, Switzerland Geneva, Switzerland – January 5, 2023: WISeKey International Holding Ltd. (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a global leader in cybersecurity, digital identity, and Internet of Things (IoT) solutions operating as a holding company, is proud to announce that in collaboration with the Cybersecurity Tech Accord, it will host a roundtable discussion on January 17, 2024 in Davos, Switzerland. The roundtable, themed “AI Unleashed: Ensuring Safety and Leveraging Decentralization,” is a landmark gathering that will dissect the burgeoning role of cybersecurity within Artificial Intelligence. It will aim to navigate the complex terrain of AI, probing the ethical, safety, and privacy challenges that accompany...

AirNet Announces Receipt of Deficiency Letter from Nasdaq

Written by Customer Service on January 5, 2024. Posted in Public Companies.

BEIJING, Jan. 05, 2024 (GLOBE NEWSWIRE) — AirNet Technology Inc., formerly known as AirMedia Group Inc. (the “Company”) (Nasdaq: ANTE), today announced that it received a notification letter dated December 29, 2023 (the “Deficiency Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market Inc. (the “Nasdaq”) notifying that the Company is no longer in compliance with the Nasdaq Listing Rule 5550(b)(1) for continued listing due to its failure to maintain a minimum of $2.5 million in stockholders’ equity. In the Company’s Form 6-K dated December 28, 2023, the Company reported a negative stockholders’ equity of approximately $25.3 million. Nasdaq also determined that the Company does not meet the alternatives of market value of listed securities or net income from continuing operations for continued listing. The...

Basilea provides portfolio status update

Written by Customer Service on January 5, 2024. Posted in Public Companies.

Clinical portfolio substantially strengthened through business development in 2023; two phase 3 studies expected to start in 2024 Cresemba in-market sales of USD 445 million, increased 22% year-on-year, in 12-month period ending September 2023; 6-months market exclusivity extension granted in the US FDA PDUFA target action date on ceftobiprole US NDA April 3; US commercialization partner expected to be announced prior to FDA decisionAllschwil, Switzerland, January 5, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported today on the progress within its R&D portfolio in 2023 and upcoming milestones and timelines. David Veitch, Chief Executive Officer, said: “We have achieved significant milestones...

OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029

Written by Customer Service on January 5, 2024. Posted in Public Companies.

Proceeds to be used for privately negotiated repurchases of common stock and outstanding 4.50% Convertible Senior Notes due 2025 MIAMI, Jan. 04, 2024 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) (the “Company”) today announced the pricing of its private offering of $200.0 million aggregate principal amount of its Convertible Senior Notes due 2029 (the “Notes”). The Company granted the initial purchaser in the offering an option to purchase, within the 13-day period beginning on, and including, the date on which the Notes are first issued, up to an additional $30.0 million aggregate principal amount of the Notes. The sale of the Notes is expected to close on January 9, 2024, subject to customary closing conditions. The Notes will be senior unsecured obligations of the Company, will bear interest at a rate of 3.75% per annum,...

Dyne Therapeutics Announces Pricing of $300 Million Public Offering of Common Stock

Written by Customer Service on January 5, 2024. Posted in Public Companies.

WALTHAM, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq:DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced the pricing of an underwritten public offering of 17,150,000 shares of its common stock at a public offering price of $17.50 per share. The gross proceeds to Dyne from the offering, before deducting underwriting discounts and commissions and offering expenses payable by Dyne, are expected to be approximately $300.1 million. All shares in the offering are being sold by Dyne. The offering is expected to close on or about January 9, 2024, subject to customary closing conditions. In addition, Dyne has granted the underwriters a 30-day option to purchase up to an additional 2,572,500...

Voyager Therapeutics Announces Pricing of Public Offering

Written by Customer Service on January 5, 2024. Posted in Public Companies.

LEXINGTON, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced the pricing of an underwritten public offering of 7,777,778 shares of its common stock at a public offering price of $9.00 per share, and, to investors who so choose in lieu of common stock, pre-funded warrants to purchase an aggregate of 3,333,333 shares of common stock at a public offering price of $8.999 per pre-funded warrant, for aggregate gross proceeds of approximately $100 million, before deducting underwriting discounts and commissions and other offering expenses payable by the Company. The purchase price per pre-funded warrant represents the per share public offering price for the common stock, minus the $0.001 per share exercise price of each...

Standard BioTools Stockholders Approve Merger with SomaLogic

Written by Customer Service on January 5, 2024. Posted in Mergers And Acquisitions.

SOUTH SAN FRANCISCO, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) — Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health, today announced that its stockholders voted to approve all proposals required to be approved in connection with the pending merger with SomaLogic (Nasdaq: SLGC) at its Special Meeting of Stockholders. “We are pleased with the outcome of today’s Special Meeting and thank our stockholders for their support for this merger,” said Michael Egholm, PhD, President and Chief Executive Officer of Standard BioTools. “Together with SomaLogic, we will have an expanded platform to better serve our customers and we believe we will be able to deliver significant shareholder value through enhanced scale and a strengthened balance sheet to fuel future growth.” Standard...

FormFactor Inc. To Present At The 26th Annual Needham Growth Conference

Written by Customer Service on January 5, 2024. Posted in Public Companies.

LIVERMORE, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) — FormFactor, Inc. (Nasdaq: FORM) is pleased to announce its participation in the 26th Annual Needham Growth Conference on January 17, 2024. FormFactor is scheduled to present on Wednesday, January 17 at 9:30AM ET. The company’s Chief Execute Officer, Michael Slessor, will present. The public is invited to listen to a live webcast of FormFactor’s presentations, which can be accessed from the investors’ section of the company’s website at www.formfactor.com. Replay of the webcast will also be available at www.formfactor.com. About FormFactor: FormFactor, Inc. (NASDAQ: FORM), is a leading provider of essential test and measurement technologies along the full IC life cycle -from characterization, modeling, reliability, and design de-bug, to qualification and production...

Dental Consumables Market Set to Soar Past USD 45.96 Billion by 2030

Written by Customer Service on January 5, 2024. Posted in Mergers And Acquisitions.

The global Dental Consumables market size is expected to reach USD 45.96 billion by 2030 and exhibit a CAGR of 7.8% in the forecast period (2023−2030), according to Skyquest’s latest research report. The increasing global prevalence of dental disorders and oral health issues, including dental caries, periodontal diseases, and tooth loss, has created a growing demand for dental treatments and procedures, boosting the consumption of dental consumables. Secondly, the aging population, particularly in developed regions, has increased demand for dental care services and prosthetic solutions like dentures and dental implants, fueling the market’s growth. Westford USA, Jan. 04, 2024 (GLOBE NEWSWIRE) — SkyQuest’s latest global research of the Dental Consumables market shows a growing emphasis on preventive dentistry,...

Day: January 5, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice